These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 28697793)

  • 1. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
    Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
    J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linc00707 promotes cell proliferation, invasion, and migration via the miR-30c/CTHRC1 regulatory loop in breast cancer.
    Yuan RX; Bao D; Zhang Y
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4863-4872. PubMed ID: 32432749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mir-30b-3p affects the migration and invasion function of ovarian cancer cells by targeting the CTHRC1 gene.
    Li Y; Zhou J; Wang J; Chen X; Zhu Y; Chen Y
    Biol Res; 2020 Mar; 53(1):10. PubMed ID: 32156314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling.
    Chen G; Wang D; Zhao X; Cao J; Zhao Y; Wang F; Bai J; Luo D; Li L
    Cancer Cell Int; 2017; 17():118. PubMed ID: 29234238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-134 inhibits melanoma growth and metastasis by negatively regulating collagen triple helix repeat containing-1 (CTHRC1).
    Li Y; Fu Y; Gao Y; Li H; Ma L; Shu C; Li N; Ma C
    Int J Clin Exp Pathol; 2018; 11(9):4319-4330. PubMed ID: 31949828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTHRC1 affects malignant tumor cell behavior and is regulated by miR-30e-5p in human prostate cancer.
    Ma Z; Chao F; Wang S; Song Z; Zhuo Z; Zhang J; Xu G; Chen G
    Biochem Biophys Res Commun; 2020 Apr; 525(2):418-424. PubMed ID: 32102754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTHRC1 overexpression promotes ectopic endometrial stromal cell proliferation, migration and invasion via activation of the Wnt/β-catenin pathway.
    Lv Y; Zhang L; Ma J; Fei X; Xu K; Lin J
    Reprod Biomed Online; 2020 Jan; 40(1):26-32. PubMed ID: 31787549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
    Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
    Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-30c inhibits pancreatic cancer cell proliferation by targeting twinfilin 1 and indicates a poor prognosis.
    Sun LL; Cheng M; Xu XD
    World J Gastroenterol; 2019 Nov; 25(42):6311-6321. PubMed ID: 31754292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer.
    Yu J; Feng J; Zhi X; Tang J; Li Z; Xu Y; Yang L; Hu Z; Xu Z
    Tumour Biol; 2015 May; 36(5):3221-9. PubMed ID: 25510669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1
    Liu J; Chen Z; Xiang J; Gu X
    Oncol Lett; 2018 Apr; 15(4):5561-5568. PubMed ID: 29556299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTHRC1 promotes human colorectal cancer cell proliferation and invasiveness by activating Wnt/PCP signaling.
    Yang XM; You HY; Li Q; Ma H; Wang YH; Zhang YL; Zhu L; Nie HZ; Qin WX; Zhang ZG; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12793-801. PubMed ID: 26722469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of CTHRC1 in proliferation, migration and invasion of human colorectal cancer cells].
    Yan L; Ye GT; Shen Z; Zhu X; Liu H; Li G
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):767-71, 776. PubMed ID: 26018280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
    Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
    J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-509-3p Suppresses Migration, Invasion, and Epithelial- Mesenchymal Transition in Melanoma Cells by Targeting Collagen Triple Helix Repeat Containing 1.
    Yuan K; Sun Y; Ji Y
    Balkan Med J; 2021 May; 38(3):177-182. PubMed ID: 33593721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.
    Ke Z; He W; Lai Y; Guo X; Chen S; Li S; Wang Y; Wang L
    Oncotarget; 2014 Oct; 5(19):9410-24. PubMed ID: 25238260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.